The radiographically diagnosed adrenal myelolipoma

what do we really know?

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Purpose: Adrenal myelolipomas are uncommon, benign tumors of the adrenal glands that are not routinely evaluated for autonomous hormone secretion or followed by repeat imaging, but may lead to retroperitoneal hemorrhage. Little is known about the natural history these tumors with the majority of previous publications being confined to case reports and small case series. Methods: We reviewed the computed tomography (CT) reports of 62,279 patients evaluated at a tertiary referral center between 2002 and 2015 for the presence of an adrenal myelolipoma >1 cm in size. We then reviewed the CT imaging and patient charts to determine tumor size, growth, evidence of retroperitoneal hemorrhage, and endocrine dysfunction. Results: We identified 150 (0.24%) patients with 155 radiographically diagnosed adrenal myelolipomas found on a CT scan during our study period. The median tumor size at discovery was 2.1 cm. Twelve (7.7%) tumors were >6 cm. Sixty-nine (46%) patients had a follow-up CT with a mean time interval between scans of 3.9 years. Eleven tumors (16%) grew over our follow-up period with a median growth rate of 0.16 cm/year. No patient developed a retroperitoneal hemorrhage. Twenty (13%) patients underwent an evaluation for endocrine dysfunction. Three patients had evidence of hypercortisolism and one patient had primary aldosteronism. Conclusion: The majority of radiographically diagnosed adrenal myelolipomas found on abdominal CT imaging are small and slow growing. Retroperitoneal hemorrhage is uncommon, but the rate of associated endocrine dysfunction may be underestimated.

Original languageEnglish (US)
Pages (from-to)1-6
Number of pages6
JournalEndocrine
DOIs
StateAccepted/In press - Sep 2 2017

Fingerprint

Myelolipoma
Tomography
Hemorrhage
Neoplasms
Hyperaldosteronism
Cushing Syndrome
Adrenal Glands
Growth
Natural History
Tertiary Care Centers
Hormones

Keywords

  • Adrenal incidentaloma
  • Adrenal myelolipoma
  • Hypercortisolism

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

The radiographically diagnosed adrenal myelolipoma : what do we really know? / Campbell, Michael; Obasi, Mary; Wu, Bingling; Corwin, Michael T; Fananapazir, Ghaneh.

In: Endocrine, 02.09.2017, p. 1-6.

Research output: Contribution to journalArticle

@article{6a7631eaa959470b85d4321ac78928e9,
title = "The radiographically diagnosed adrenal myelolipoma: what do we really know?",
abstract = "Purpose: Adrenal myelolipomas are uncommon, benign tumors of the adrenal glands that are not routinely evaluated for autonomous hormone secretion or followed by repeat imaging, but may lead to retroperitoneal hemorrhage. Little is known about the natural history these tumors with the majority of previous publications being confined to case reports and small case series. Methods: We reviewed the computed tomography (CT) reports of 62,279 patients evaluated at a tertiary referral center between 2002 and 2015 for the presence of an adrenal myelolipoma >1 cm in size. We then reviewed the CT imaging and patient charts to determine tumor size, growth, evidence of retroperitoneal hemorrhage, and endocrine dysfunction. Results: We identified 150 (0.24{\%}) patients with 155 radiographically diagnosed adrenal myelolipomas found on a CT scan during our study period. The median tumor size at discovery was 2.1 cm. Twelve (7.7{\%}) tumors were >6 cm. Sixty-nine (46{\%}) patients had a follow-up CT with a mean time interval between scans of 3.9 years. Eleven tumors (16{\%}) grew over our follow-up period with a median growth rate of 0.16 cm/year. No patient developed a retroperitoneal hemorrhage. Twenty (13{\%}) patients underwent an evaluation for endocrine dysfunction. Three patients had evidence of hypercortisolism and one patient had primary aldosteronism. Conclusion: The majority of radiographically diagnosed adrenal myelolipomas found on abdominal CT imaging are small and slow growing. Retroperitoneal hemorrhage is uncommon, but the rate of associated endocrine dysfunction may be underestimated.",
keywords = "Adrenal incidentaloma, Adrenal myelolipoma, Hypercortisolism",
author = "Michael Campbell and Mary Obasi and Bingling Wu and Corwin, {Michael T} and Ghaneh Fananapazir",
year = "2017",
month = "9",
day = "2",
doi = "10.1007/s12020-017-1410-6",
language = "English (US)",
pages = "1--6",
journal = "Endocrine",
issn = "1355-008X",
publisher = "Humana Press",

}

TY - JOUR

T1 - The radiographically diagnosed adrenal myelolipoma

T2 - what do we really know?

AU - Campbell, Michael

AU - Obasi, Mary

AU - Wu, Bingling

AU - Corwin, Michael T

AU - Fananapazir, Ghaneh

PY - 2017/9/2

Y1 - 2017/9/2

N2 - Purpose: Adrenal myelolipomas are uncommon, benign tumors of the adrenal glands that are not routinely evaluated for autonomous hormone secretion or followed by repeat imaging, but may lead to retroperitoneal hemorrhage. Little is known about the natural history these tumors with the majority of previous publications being confined to case reports and small case series. Methods: We reviewed the computed tomography (CT) reports of 62,279 patients evaluated at a tertiary referral center between 2002 and 2015 for the presence of an adrenal myelolipoma >1 cm in size. We then reviewed the CT imaging and patient charts to determine tumor size, growth, evidence of retroperitoneal hemorrhage, and endocrine dysfunction. Results: We identified 150 (0.24%) patients with 155 radiographically diagnosed adrenal myelolipomas found on a CT scan during our study period. The median tumor size at discovery was 2.1 cm. Twelve (7.7%) tumors were >6 cm. Sixty-nine (46%) patients had a follow-up CT with a mean time interval between scans of 3.9 years. Eleven tumors (16%) grew over our follow-up period with a median growth rate of 0.16 cm/year. No patient developed a retroperitoneal hemorrhage. Twenty (13%) patients underwent an evaluation for endocrine dysfunction. Three patients had evidence of hypercortisolism and one patient had primary aldosteronism. Conclusion: The majority of radiographically diagnosed adrenal myelolipomas found on abdominal CT imaging are small and slow growing. Retroperitoneal hemorrhage is uncommon, but the rate of associated endocrine dysfunction may be underestimated.

AB - Purpose: Adrenal myelolipomas are uncommon, benign tumors of the adrenal glands that are not routinely evaluated for autonomous hormone secretion or followed by repeat imaging, but may lead to retroperitoneal hemorrhage. Little is known about the natural history these tumors with the majority of previous publications being confined to case reports and small case series. Methods: We reviewed the computed tomography (CT) reports of 62,279 patients evaluated at a tertiary referral center between 2002 and 2015 for the presence of an adrenal myelolipoma >1 cm in size. We then reviewed the CT imaging and patient charts to determine tumor size, growth, evidence of retroperitoneal hemorrhage, and endocrine dysfunction. Results: We identified 150 (0.24%) patients with 155 radiographically diagnosed adrenal myelolipomas found on a CT scan during our study period. The median tumor size at discovery was 2.1 cm. Twelve (7.7%) tumors were >6 cm. Sixty-nine (46%) patients had a follow-up CT with a mean time interval between scans of 3.9 years. Eleven tumors (16%) grew over our follow-up period with a median growth rate of 0.16 cm/year. No patient developed a retroperitoneal hemorrhage. Twenty (13%) patients underwent an evaluation for endocrine dysfunction. Three patients had evidence of hypercortisolism and one patient had primary aldosteronism. Conclusion: The majority of radiographically diagnosed adrenal myelolipomas found on abdominal CT imaging are small and slow growing. Retroperitoneal hemorrhage is uncommon, but the rate of associated endocrine dysfunction may be underestimated.

KW - Adrenal incidentaloma

KW - Adrenal myelolipoma

KW - Hypercortisolism

UR - http://www.scopus.com/inward/record.url?scp=85028759874&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028759874&partnerID=8YFLogxK

U2 - 10.1007/s12020-017-1410-6

DO - 10.1007/s12020-017-1410-6

M3 - Article

SP - 1

EP - 6

JO - Endocrine

JF - Endocrine

SN - 1355-008X

ER -